---
figid: PMC8395387__41575_2021_492_Fig2_HTML
figtitle: Pathophysiology of thrombosis in IBD
organisms:
- Homo sapiens
- Clostridioides difficile
- Myristica fragrans
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8395387
filename: 41575_2021_492_Fig2_HTML.jpg
figlink: /pmc/articles/PMC8395387/figure/Fig2/
number: F2
caption: 'This figure depicts the alterations involved in the increased risk of thrombosis
  in patients with inflammatory bowel disease (IBD): platelet alterations leading
  to activation; procoagulant alterations leading to activation of the coagulation
  cascade; dysregulated fibrinolysis. ADAMTS13, a disintegrin and metalloproteinase
  with a thrombospondin type 1 motif, member 13; GPIIb/GPIIIA, glycoprotein IIb/IIIa;
  PAI1, plasminogen activator inhibitor 1; PAR, protease-activated receptor; PF4,
  platelet factor 4; TAFI, thrombin-activatable fibrinolysis inhibitor; TF, tissue
  factor; TFPI, tissue factor pathway inhibitor; tPA, tissue plasminogen activator;
  uPA, urokinase-type plasminogen activator; VWF, von Willebrand factor. Elements
  of Fig. 2 adapted with permission from ref., Elsevier.'
papertitle: International consensus on the prevention of venous and arterial thrombotic
  events in patients with inflammatory bowel disease.
reftext: Pablo A. Olivera, et al. Nat Rev Gastroenterol Hepatol. 2021;18(12):857-873.
year: '2021'
doi: 10.1038/s41575-021-00492-8
journal_title: Nature Reviews. Gastroenterology & Hepatology
journal_nlm_ta: Nat Rev Gastroenterol Hepatol
publisher_name: Nature Publishing Group UK
keywords: Inflammatory bowel disease | Cardiovascular diseases
automl_pathway: 0.9133837
figid_alias: PMC8395387__F2
figtype: Figure
redirect_from: /figures/PMC8395387__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8395387__41575_2021_492_Fig2_HTML.html
  '@type': Dataset
  description: 'This figure depicts the alterations involved in the increased risk
    of thrombosis in patients with inflammatory bowel disease (IBD): platelet alterations
    leading to activation; procoagulant alterations leading to activation of the coagulation
    cascade; dysregulated fibrinolysis. ADAMTS13, a disintegrin and metalloproteinase
    with a thrombospondin type 1 motif, member 13; GPIIb/GPIIIA, glycoprotein IIb/IIIa;
    PAI1, plasminogen activator inhibitor 1; PAR, protease-activated receptor; PF4,
    platelet factor 4; TAFI, thrombin-activatable fibrinolysis inhibitor; TF, tissue
    factor; TFPI, tissue factor pathway inhibitor; tPA, tissue plasminogen activator;
    uPA, urokinase-type plasminogen activator; VWF, von Willebrand factor. Elements
    of Fig. 2 adapted with permission from ref., Elsevier.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TFPI
  - TF
  - F10
  - F9
  - AK3
  - F8
  - FGA
  - FGB
  - FGG
  - SERPINE1
  - HADHA
  - PLAT
  - PLAU
  - PRAP1
  - CD40LG
  - PLG
  - PAWR
  - F2RL3
  - PWAR4
  - MARK2
  - F2R
  - NR1I2
  - SLC52A2
  - PWAR1
  - ITGA2B
  - CPB2
  - SET
  - WDTC1
  - ADAMTS13
  - VWF
  - PF4
  - F11
  - tf
  - upd1
  - Lkb1
  - par-1
  - adp
  - pf-4
---
